ALKS

Alkermes (ALKS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

What's Going on With Alkermes Stock Monday? - Alkermes (NASDAQ:ALKS)

TD Cowen raises Alkermes stock price target to $57 on drug data

Mizuho raises Alkermes stock price target to $65 on narcolepsy drug potential

Price to sales forward of Alkermes plc – NASDAQ:ALKS

Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS)